(Date:12/2/2009)...RUSALEM, Israel, December 2 Gamida...ng the preclinical (animal study) safety and,effic...ology from Weill,Cornell Medical College and Gamid...herited anemias such as Cooley,s Anemia. , ...es to expand, ex vivo,populations of stem/progeni...
(Date:12/2/2009)...AI, Dec. 2 /PRNewswire-Asia/ -- The world is going...il and uncertainty is part of many,businesses and ...has been,relatively immune to the economic downtur... During the midst of the difficult times this ...on inaugurated an R&D center in Shanghai, the ...
(Date:12/1/2009)...K, Dec. 1 Reportlinker.com announc...in its catalogue: ,, Chromium - Global Market...494/Chromium---Global-Market-Trends.html ,, Wo...d by stainless steel, while growth in aerospace an... for growth of chromium metal. Environmental const...
(Date:12/1/2009)...ajority Leader Richard Gephardt Brings Together A-...Communities for "Best and Brightest Forum on Medi... Several of New Jersey,s...earch, medicine and technology gathered today at t...e of medical innovation in New Jersey, and through...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5...al Trial Capability into the Frontage ...ne 24 Frontage Laboratories,( http://www.frontage... P.R.,China), a leading high quality provider of b...rvices to the pharmaceutical industry, announced t...Biomedical Research, Inc.,(ABR) ( http://www.abr-p...
...Strengthens Research & Development Team, CLINTON,...egrated critical care biotherapeutics company, ann...duced as Vice President of Translational,Medicine,...President for,Research and Development of Ikaria.,... Cooreman is,responsible for leading the Company,s...
...24 Portola,Pharmaceuticals, a clinical-stage biop...s for acute and chronic cardiovascular and,inflamm...joined the company,as Vice President of Business a...ible for the company,s corporate partnering activi...portfolio of clinical and preclinical,programs. He...
Other Biology Technology:Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 2Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 3Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 4Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine 2Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine 3Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations 2Pyrophosphate Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
beta-galactosidase Colorimetric Assay Kit from Cell Signaling Technology
Human Serum Type AB from Irvine Scientific
Normal Human Serum from CHEMICON
Biology Products: